Show simple item record

FieldValueLanguage
dc.contributor.authorLindsay, J
dc.contributor.authorKabir, M
dc.contributor.authorGilroy, N
dc.contributor.authorDyer, G
dc.contributor.authorBrice, L
dc.contributor.authorMoore, J
dc.contributor.authorGreenwood, M
dc.contributor.authorHertzberg, M
dc.contributor.authorGottlieb, D
dc.contributor.authorLarsen, SR
dc.contributor.authorHogg, M
dc.contributor.authorBrown, L
dc.contributor.authorHuang, G
dc.contributor.authorTan, J
dc.contributor.authorWard, C
dc.contributor.authorKerridge, I
dc.date.accessioned2016-11-03
dc.date.available2016-11-03
dc.date.issued2016-01-01
dc.identifier.citationLindsay, J., Kabir, M., Gilroy, N., Dyer, G., Brice, L., Moore, J., Greenwood, M., Hertzberg, M., Gottlieb, D., Larsen, S. R., Hogg, M., Brown, L., Huang, G., Tan, J., Ward, C. and Kerridge, I. (2016), Epidemiology of complementary and alternative medicine therapy use in allogeneic hematopoietic stem cell transplant survivorship patients in Australia. Cancer Med. doi:10.1002/cam4.889. Published online 27 Oct 2016en_AU
dc.identifier.urihttp://hdl.handle.net/2123/15847
dc.description.abstractIn addition to prescribed conventional medicines, many allogeneic hematopoietic stem cell transplant (HSCT) survivors also use complementary and alternative medical therapies (CAM), however, the frequency and types of CAMs used by allogeneic HSCT survivors remain unclear. Study participants were adults who had undergone an allogeneic HSCT between 1st January 2000 and 31st December 2012. Participants completed a 402-item questionnaire regarding the use of CAM, medical complications, specialist referrals, medications and therapies, infections, vaccinations, cancer screening, lifestyle, and occupational issues and relationship status following stem cell transplantation. A total of 1475 allogeneic HSCT were performed in the study period. Of the 669 recipients known to be alive at study sampling, 583 were contactable and were sent study packs. Of 432 participants who returned the completed survey (66% of total eligible, 76% of those contacted), 239 (54.1%) HSCT survivors used at least one form of CAM. These included dietary modification (13.6%), vitamin therapy (30%), spiritual or mind–body therapy (17.2%), herbal supplements (13.5%), manipulative and body-based therapies (26%), Chinese medicine (3.5%), reiki (3%), and homeopathy (3%). These results definitively demonstrate that a large proportion of HSCT survivors are using one or more form of CAM therapy. Given the potential benefits demonstrated by small studies of specific CAM therapies in this patient group, as well as clearly documented therapies with no benefit or even toxicity, this result shows there is a large unmet need for additional studies to ascertain efficacy and safety of CAM therapies in this growing population.en_AU
dc.description.sponsorshipfunded by the New South Wales Agency for Clinical Innovation (ACI) Blood and Marrow Transplant Network and supported by the Northern Blood Research Centreen_AU
dc.language.isoenen_AU
dc.publisherWileyen_AU
dc.subjectCAM therapyen_AU
dc.subjectefficacy and safetyen_AU
dc.subjectallogeneic hematopoietic stem cell transplant (HSCT) survivorsen_AU
dc.subjectcomplementary and alternative medical therapies (CAM)en_AU
dc.subjectPatient questionnaireen_AU
dc.subjectstem cell transplantation.en_AU
dc.titleEpidemiology of complementary and alternative medicine therapy use in allogeneic hematopoietic stem cell transplant survivorship patients in Australiaen_AU
dc.typeArticleen_AU


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.